These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 26988235

  • 1. [High levels of atrial natriuretic peptide and copeptin and mortality risk].
    Rey C, García-Cendón C, Martínez-Camblor P, López-Herce J, Concha-Torre A, Medina A, Vivanco-Allende A, Mayordomo-Colunga J.
    An Pediatr (Barc); 2016 Dec; 85(6):284-290. PubMed ID: 26988235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia.
    Seligman R, Seligman BG, Teixeira PJ.
    J Bras Pneumol; 2011 Dec; 37(4):495-503. PubMed ID: 21881740
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of MR-proANP and copeptin for sepsis diagnosis after burn injury.
    Gille J, Schmidt J, Kremer T, Sablotzki A.
    J Crit Care; 2019 Aug; 52():149-155. PubMed ID: 31075618
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L, Giesa C, Ewig S.
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O, Cevik E, Acar A, Kaya C, Ardic S, Comert B, Yokusoglu M, Bilgi C, Meisner M, Madsen T.
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [Abstract] [Full Text] [Related]

  • 12. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.
    Miller WL, Hartman KA, Grill DE, Struck J, Bergmann A, Jaffe AS.
    Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C, Seissler J, Jordan J, Rathmann W, Koenig W, Roden M, Mansmann U, Herder C, Peters A, Thorand B, Then C.
    Cardiovasc Diabetol; 2020 Oct 16; 19(1):178. PubMed ID: 33066780
    [Abstract] [Full Text] [Related]

  • 15. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
    Boeck L, Eggimann P, Smyrnios N, Pargger H, Thakkar N, Siegemund M, Marsch S, Rakic J, Tamm M, Stolz D.
    Eur Respir J; 2011 Mar 16; 37(3):595-603. PubMed ID: 20530040
    [Abstract] [Full Text] [Related]

  • 16. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA.
    J Am Coll Cardiol; 2014 Apr 29; 63(16):1644-53. PubMed ID: 24530676
    [Abstract] [Full Text] [Related]

  • 17. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
    Düngen HD, Tscholl V, Obradovic D, Radenovic S, Matic D, Musial Bright L, Tahirovic E, Marx A, Inkrot S, Hashemi D, Veskovic J, Apostolovic S, von Haehling S, Doehner W, Cvetinovic N, Lainscak M, Pieske B, Edelmann F, Trippel T, Loncar G.
    ESC Heart Fail; 2018 Apr 29; 5(2):288-296. PubMed ID: 29476612
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S.
    Am J Emerg Med; 2014 Apr 29; 32(4):334-41. PubMed ID: 24559907
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.